Substituted 4-methylquinolines as a new class of anti-tuberculosis agents

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 6, 2003, Pages 1051-1054

  Jain, Rahul ^a   Vaitilingam, Balasubramanian ^a   Nayyar, Amit ^a   Palde, Prakash B ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOPENTYL 4 METHYLQUINOLINE; 2,8 DICYCLOBUTYL 4 METHYLQUINOLINE; QUINOLINE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SUBSTITUTION REACTION;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0037463796     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00074-X     Document Type: Article

References (23)

1. (a) World Health Organization. In Anti-tuberculosis Drug Resistance in the World. The WHO/IUALTD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. World Health Organization (Publication # WHO/TB/ 97.229), Geneva, Switzerland, 1997.
2. (b) Duncan K. Chem. Ind. 1997;861
3. (c) Shinnick T.M., King C.H., Quinn F.D. Am. J. Med. Sci. 309:1995;92.
4. World Health Organization. Global Tuberculosis Control; WHO Report 2001; World Health Organization, (Publication # WHO/CDS/TB/2001.287), Geneva, Switzerland, 2001.
5. Snider D.E. Jr., LaMontagane J.R. J. Infect. Dis. 169:1994;1189.
6. McConnell J. The Lancet. 351:1998;852.
7. Ken D. J. Pharm. Pharmacol. 49:1997;1.
8. David S. Tuberculosis. 1996;Spring-Verlag Ed, New York.
9. Jain R., Cohen L.A., El-Kadi N.A., King M.M. Tetrahedron. 53:1997;2365.
10. Jain R., Cohen L.A., King M.M. Tetrahedron. 53:1997;4539.
11. Narayanan S., Suryanarayana V., Jain R. Bioorg. Med. Chem. Lett. 11:2001;1133.
12. (a). For mechanistic details of the homolytic radical reaction, please see: Minisci F., Bernardi R., Bertini F., Galli R., Perchinummo M. Tetrahedron. 27:1971;3575
13. (b) Minisci F., Visamara E., Fontana F., Morini G., Serravalle M., Giordano C. J. Org. Chem. 52:1987;730
14. (c) Giordano C., Minisci F., Visamara E., Levi S. J. Org. Chem. 51:1986;536
15. (d) Visamara E., Serravalle M., Minisci F. Tetrahedron Lett. 27:1986;3187
16. (e) Anderson J.M., Kochi J.K. J. Am. Chem. Soc. 92:1970;1651
17. (f) Minisci F. Synthesis. 1973;1
18. (g) Minisci F., Vismara E., Fontana F. Heterocycles. 28:1989;489.
19. Minisci F., Fontana F., Pianese G., Yan Y.M. J. Org. Chem. 58:1993;4207.
20. 3) m/z 184 (M+1).
21. +).
22. Franzblau S.G., Witzig R.S., McLaughlin J.C., Torres P., Madico G., Herandez A., Degnan M.T., Cook M.B., Quenzer V.K., Ferguson R.M., Gilman R.H. J. Clin. Microb. 36:1998;362.
23. Collins L., Franzblau S.G. Antimicrob. Agents Chemother. 41:1997;1004.